SCHEMBL6137675

SCHEMBL6137675

N#Cc1ccc2c(c1)C1CCCC1(F)C(N)=N2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 9/20 0.67
NOS1 P29475 9/20 0.67
NOS2 P35228 9/20 0.67
CHRNA1 P02708 1/20 0.33
CHRNG P07510 1/20 0.33
CHRNB1 P11230 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
CHRND Q07001 1/20 0.33
IRAK4 Q9NWZ3 2/20 0.32
SLC6A4 P31645 1/20 0.32
KDM1A O60341 2/20 0.32
APP P05067 1/20 0.31
BACE1 P56817 1/20 0.31
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31
CYP17A1 P05093 1/20 0.31
CYP19A1 P11511 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137722 0.82 NOS3 (0.74) NOS3NOS1NOS2KDM1A
SCHEMBL6137347 0.82 NOS3 (0.74) NOS3NOS1NOS2
SCHEMBL6137320 0.81 NOS3 (1.00) NOS3NOS1NOS2
SCHEMBL6137334 0.81 NOS3 (0.72) NOS3NOS1NOS2KDM1AAPP
SCHEMBL6137342 0.79 NOS3 (0.69) NOS3NOS1NOS2CHRNB2CHRNB4
SCHEMBL6137760 0.78 NOS3 (0.67) NOS3NOS1NOS2KDM1ACYP11B1
SCHEMBL6137735 0.76 NOS3 (0.65) NOS3NOS1NOS2CHRNB4CHRNA3
SCHEMBL6137654 0.74 NOS3 (0.68) NOS3NOS1NOS2
SCHEMBL6645425 0.68 NOS1 (1.00) NOS3NOS1NOS2
SCHEMBL6646269 0.60 NOS1 (0.79) NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed